Alzheimer’s disease and language impairments: social intervention and medical treatment
暂无分享,去创建一个
Blanka Klimova | Kamil Kuca | Jakub Hort | Petra Maresova | Martin Valis | M. Valis | J. Hort | K. Kuča | P. Marešová | B. Klimova
[1] R. Laforce,et al. [Language deficits in major forms of dementia and primary progressive aphasias: an update according to new diagnostic criteria]. , 2014, Geriatrie et psychologie neuropsychiatrie du vieillissement.
[2] J. Cummings,et al. Effect of donepezil on cognition in severe Alzheimer's disease: a pooled data analysis. , 2010, Journal of Alzheimer's disease : JAD.
[3] C. Beck,et al. Will a healthy lifestyle help prevent Alzheimer's disease? , 2003, Annual review of public health.
[4] M. Freedman,et al. Bilingualism as a protection against the onset of symptoms of dementia , 2007, Neuropsychologia.
[5] S. Cappa,et al. The effects of ageing and Alzheimer's disease on semantic and gender priming. , 2004, Brain : a journal of neurology.
[6] Dr.Lynne Corner. Cognitive rehabilitation in dementia , 2002 .
[7] B. Winblad,et al. Donepezil treatment in severe Alzheimer's disease: a pooled analysis of three clinical trials , 2009, Current medical research and opinion.
[8] Laura Smith-Olinde,et al. Efficacy of language assessment in Alzheimer’s disease: comparing in-person examination and telemedicine , 2006, Clinical interventions in aging.
[9] Mustafa Atalay,et al. Exercise plays a preventive role against Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.
[10] C. W. Picanço-Diniz,et al. CANTAB object recognition and language tests to detect aging cognitive decline: an exploratory comparative study , 2014, Clinical interventions in aging.
[11] Denise C. Park,et al. Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[12] J. Olin,et al. Effects of Oral Rivastigmine on Cognitive Domains in Mild-to-Moderate Alzheimer’s Disease , 2010, American journal of Alzheimer's disease and other dementias.
[13] R. Ihl,et al. Treatment effects of Memantine on language in moderate to severe Alzheimer's disease patients , 2009, Alzheimer's & Dementia.
[14] E. Capitani,et al. Phonetically Cued Word-Fluency, Gender Differences and Aging: A Reappraisal , 1998, Cortex.
[15] H. Buschke,et al. Leisure activities and the risk of dementia in the elderly. , 2003, The New England journal of medicine.
[16] Blanka Klímová,et al. Alzheimers disease: cost cuts call for novel drugs development and national strategy. , 2015, Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti.
[17] Steven H Ferris,et al. Language impairment in Alzheimer’s disease and benefits of acetylcholinesterase inhibitors , 2013, Clinical interventions in aging.
[18] D N Ripich,et al. Functional Communication with AD Patients: A Caregiver Training Program , 1994, Alzheimer disease and associated disorders.
[19] T. Fritsch,et al. Effects of Educational Attainment and Occupational Status on Cognitive and Functional Decline in Persons With Alzheimer-Type Dementia , 2002, International Psychogeriatrics.
[20] B. Winblad,et al. Mortality and treatment costs have a great impact on the cost-effectiveness of disease modifying treatment in Alzheimer's disease--a simulation study. , 2013, Current Alzheimer research.
[21] F. Schmitt,et al. Analyzing the impact of 23 mg/day donepezil on language dysfunction in moderate to severe Alzheimer's disease , 2011, Alzheimer's Research & Therapy.
[22] Sture Eriksson,et al. Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study , 2006, The Lancet.
[23] A REVIEW ON ALZHEIMER'S DISEASE: ITS CAUSE, SYMPTOMS,AND TREATMENT AT WORLD WIDE , 2010 .
[24] Jean-François Dartigues,et al. The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study. , 2005, Brain : a journal of neurology.
[25] M. Freedman,et al. Delaying the onset of Alzheimer disease , 2010, Neurology.
[26] D. Tang‐Wai,et al. Assessment of Language Function in Dementia , 2022 .
[27] J. Cooper,et al. Drug treatment of Alzheimer's disease. , 1991, Archives of internal medicine.
[28] M. Hofmann,et al. Advances in Diagnosis and Treatment of Alzheimer's Disease , 2002 .
[29] S. Chapman,et al. Evidence-based practice recommendations for dementia: educating caregivers on Alzheimer's disease and training communication strategies , 2007 .
[30] Y. Stern,et al. Diabetes mellitus and the risk of dementia , 1999, Neurology.
[31] S. Pekkala,et al. Semantic Fluency in Mild and Moderate Alzheimer's Disease , 2004 .
[32] S. E. Black,et al. Donepezil preserves cognition and global function in patients with severe Alzheimer disease , 2007, Neurology.
[33] J. Olin,et al. Reviews: Effects of Transdermal Rivastigmine on ADAS-Cog Items in Mild-to-Moderate Alzheimer’s Disease , 2010, American journal of Alzheimer's disease and other dementias.
[34] M. Kivipelto,et al. Alzheimer’s disease — The ways of prevention , 2008, The journal of nutrition, health & aging.
[35] B. Winblad,et al. Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease , 2005, The Lancet Neurology.
[36] Robert A. Israel,et al. International Classification of Diseases (ICD) , 2005 .
[37] J. Klimeš,et al. Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine , 2014, Expert opinion on drug safety.
[38] A. Wimo,et al. Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial , 2009, The Lancet Neurology.
[39] M. L. Hummert,et al. Investigating the effects of communication problems on caregiver burden. , 2005, The journals of gerontology. Series B, Psychological sciences and social sciences.
[40] I. Lieberburg,et al. Lethality of Alzheimer Disease and Its Impact on Nursing Home Placement , 2010, Alzheimer disease and associated disorders.
[41] T. Gale,et al. ‘Normal’ semantic–phonemic fluency discrepancy in Alzheimer's disease? A meta-analytic study , 2010, Cortex.
[42] E. Schwam,et al. Cognition and Function in Alzheimer’s Disease: Identifying the Transitions from Moderate to Severe Disease , 2010, Dementia and Geriatric Cognitive Disorders.
[43] K. Kuča,et al. A resurrection of 7-MEOTA: a comparison with tacrine. , 2013, Current Alzheimer research.
[44] K. Hilari,et al. What are the important factors in health-related quality of life for people with aphasia? A systematic review. , 2012, Archives of physical medicine and rehabilitation.
[45] V. Andrisano,et al. Multitarget drug design strategy: quinone-tacrine hybrids designed to block amyloid-β aggregation and to exert anticholinesterase and antioxidant effects. , 2014, Journal of medicinal chemistry.
[46] J. Orange,et al. Enhancing Communication in Dementia of the Alzheimer's Type , 1998 .
[47] F. Craik,et al. Bilingualism: consequences for mind and brain , 2012, Trends in Cognitive Sciences.